Zobrazeno 1 - 10
of 22
pro vyhledávání: '"E. Ösby"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Europe PubMed Central
The monoclonal antibodies against CD8 (T suppressor/cytotoxic) antigen (Leu2/OKT8) were found to bind to leukaemic lymphocytes from a patient with chronic lymphocytic leukaemia. The cells also had an unusual type of rod-like cytoplasmic immunoglobuli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c2725bd5304b715bcbcd966eb331b4
https://doi.org/10.1111/j.1600-0609.1987.tb00775.x
https://doi.org/10.1111/j.1600-0609.1987.tb00775.x
Publikováno v:
British Journal of Haematology. 51:531-539
Summary. Peripheral neuropathy has been described in malignant plasma cell dyscrasias such as multiple myeloma and Waldenstrom's macroglobulinaemia. Since it is not known whether the neuropathy is related to the plasma cell disorder or is a paramalig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7ddf279ef9628ffcc454ec8d42cfd5
https://doi.org/10.1111/j.1365-2141.1982.00531.x
https://doi.org/10.1111/j.1365-2141.1982.00531.x
Autor:
Hannu Pertovaara, Hans Hagberg, Harald Anderson, John Myhre, Björn Nilsson, E. Ösby, Harald Holte, Stein Kvaløy, Lasse Teerenhovi, Eva Cavallin-Ståhl, Magnus Björkholm, Åke Öst
Publikováno v:
Annals of Oncology. 18:1085-1089
Background: Secondary central nervous system (CNS) involvement by aggressive lymphoma is a well-known and dreadful clinical complication. The incidence and risk factors for CNS manifestation were studied in a large cohort of elderly (> 60 years) pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471b23438801d13029ddb8816adfd8b2
https://doi.org/10.1093/annonc/mdm073
https://doi.org/10.1093/annonc/mdm073
Autor:
null The French Cooperative Group on CLL, S Johnson, A.G Smith, H Löffler, E Ösby, G Juliusson, B Emmerich, P.J Wyld, W Hiddemann
Publikováno v:
The Lancet. 347:1432-1438
Background: Fludarabine seems to be a promising treatment for patients with advanced chronic lymphocytic leukaemia (CLL). We compared fludarabine therapy with the combination of cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of CLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e8f4675f49d39398ebeab0c641cdbe5
https://doi.org/10.1016/s0140-6736(96)91681-5
https://doi.org/10.1016/s0140-6736(96)91681-5
Publikováno v:
European Journal of Haematology. 39:86-87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17fbce3df971f89cfcd8fda45338b5df
https://doi.org/10.1111/j.1600-0609.1987.tb00171.x
https://doi.org/10.1111/j.1600-0609.1987.tb00171.x
Autor:
Magnus Björkholm, A. Hedlund, P. Bernell, G. Grimfors, K. Merk, S. Widell, E. Ösby, Jan Liliemark, Fredrik Celsing, E. Svedmyr
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(11)
Summary Background Second- and third-generation chemotherapy protocols for the treatment of aggressive non-Hodgkin’s lymphomas (NHL) have considerable, and age-related, toxic effects. In addition, they do not seem to prolong overall survival in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c2555902c18838de9292e654d16e10
https://pubmed.ncbi.nlm.nih.gov/9862052
https://pubmed.ncbi.nlm.nih.gov/9862052
Autor:
L. Teerenhovi, S. Kvalöy, Hannu Pertovaara, John Myhre, H. Hagberg, E. Cavallin-Ståhl, E. Ösby, Harald Holte, H. Anderson, Å. Öst, Magnus Björkholm
Publikováno v:
Blood. 106:3333-3333
Introduction: Manifestation of central nervous system (CNS) disease in patients with aggressive non-Hodgkin’s lymphoma (NHL) during or after first line treatment is often a devastating condition, which is associated with a poor prognosis. There is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae2c273be962f6f853a0081739814d4
https://doi.org/10.1182/blood.v106.11.3333.3333
https://doi.org/10.1182/blood.v106.11.3333.3333
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Neurology. 228:185-194
It is well known that peripheral neuropathy occurs in patients with myeloma or macroglobulinaemia, but its pathogenesis is still obscure. In recent years, neuropathy has also been reported in association with benign monoclonal or oligoclonal gammopat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63edc036155647fd11e0973c0bf186fe
https://doi.org/10.1007/bf00313731
https://doi.org/10.1007/bf00313731